What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Patrick J. Pagano mainly investigates Superoxide, Endocrinology, Internal medicine, Reactive oxygen species and Biochemistry.
His work carried out in the field of Superoxide brings together such families of science as Blood vessel, Angiotensin II, NADPH oxidase and Molecular biology.
The Angiotensin II study combines topics in areas such as Oxidase test, P22phox and NAD+ kinase.
His Endocrinology study deals with Xanthine oxidase intersecting with Enzyme inhibitor, Intracellular and TUNEL assay.
His research in Reactive oxygen species intersects with topics in Fibroblast and Adrenergic receptor.
His Biochemistry research is multidisciplinary, relying on both Nitric oxide and Cell biology.
His most cited work include:
- Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle (1529 citations)
- Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2− and Systolic Blood Pressure in Mice (542 citations)
- Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. (538 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, NADPH oxidase, Endocrinology, Cell biology and Superoxide.
His research links Cardiology with Internal medicine.
As part of the same scientific family, Patrick J. Pagano usually focuses on NADPH oxidase, concentrating on Oxidase test and intersecting with NAD+ kinase.
His Cell biology research incorporates elements of Apoptosis, CD47, Vascular smooth muscle and Paracrine signalling.
His research integrates issues of Blood vessel, Xanthine oxidase, Cytochrome c, Molecular biology and Nitric oxide in his study of Superoxide.
Patrick J. Pagano usually deals with Angiotensin II and limits it to topics linked to Adventitia and Vascular disease.
He most often published in these fields:
- Internal medicine (40.67%)
- NADPH oxidase (34.67%)
- Endocrinology (35.33%)
What were the highlights of his more recent work (between 2014-2021)?
- Cell biology (30.00%)
- NADPH oxidase (34.67%)
- Pulmonary hypertension (10.67%)
In recent papers he was focusing on the following fields of study:
Cell biology, NADPH oxidase, Pulmonary hypertension, Oxidative stress and Reactive oxygen species are his primary areas of study.
His Cell biology research is multidisciplinary, incorporating perspectives in Transcription, Transcription factor, Vascular smooth muscle and Superoxide.
His NADPH oxidase study combines topics from a wide range of disciplines, such as Oxidase test and Medicinal chemistry.
Pulmonary hypertension is a primary field of his research addressed under Internal medicine.
His study explores the link between Internal medicine and topics such as Cardiology that cross with problems in Cause of death.
His Endocrinology research includes themes of Thrombospondin 1 and Age related.
Between 2014 and 2021, his most popular works were:
- Platelet-derived HMGB1 is a critical mediator of thrombosis. (134 citations)
- NADPH oxidases: key modulators in aging and age-related cardiovascular diseases? (75 citations)
- MEF2B-Nox1 Signaling Is Critical for Stretch-Induced Phenotypic Modulation of Vascular Smooth Muscle Cells (50 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His main research concerns Cell biology, Reactive oxygen species, NADPH oxidase, Oxidative stress and NOX1.
His work carried out in the field of Cell biology brings together such families of science as Angiotensin II and Nuclear DNA.
His Reactive oxygen species study is focused on Biochemistry in general.
His NADPH oxidase study integrates concerns from other disciplines, such as Oxidase test and Pathology.
His NOX1 research focuses on Vascular smooth muscle and how it connects with Hemodynamics, Function, Anatomy and Superoxide.
He is investigating Myocyte as part of his Endocrinology and Internal medicine and Myocyte study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
